Asthma
Conference Coverage
Uptick found in severe allergy shot reactions
ATLANTA – There has been an uptick in reports of severe grade 4 reactions to subcutaneous allergen immunotherapy for reasons that are not yet...
Conference Coverage
Chronic rhinosinusitis exacerbation factors identified
ATLANTA – Clinical factors associated with acute exacerbations of chronic rhinosinusitis include female sex, nonwhite race, and a higher body mass...
From the Journals
Asthma ruled out in 33% of diagnosed adults
Asthma was ruled out in 33% of adults in the general Canadian population who had been diagnosed by a physician during the preceding 5 years,...
Conference Coverage
Survey shines new light on weighty comorbidity burden in adult atopic dermatitis
VIENNA – Newly enhanced appreciation of the profound burden of comorbidities associated with adult atopic dermatitis is provided by the Liberty AD...
News
EpiPen cost increases far exceed overall medical inflation
Total Medicare part D spending on EpiPen auto-injectors rose from $7.0 million in 2007 to $87.9 million in 2014, according to the Kaiser Family...
News
Mylan’s generic EpiPen – a price break or marketing maneuver?
Conference Coverage
Crisaborole’s safety holds up in long-term atopic dermatitis trial
Key clinical point: The topical phosphodiesterase-4 inhibitor crisaborole was safe and well tolerated for up to 48 weeks in patients with mild-to-...
News
Atopic dermatitis increases risk of ADHD, comorbidities add to it
Atopic dermatitis (AD) is associated with an increased risk for attention-deficit/hyperactivity disorder (ADHD) in children and adults, and a...
News
Predictors of abnormal longitudinal patterns of lung-function growth and decline
Detection of an abnormal trajectory by means of early and ongoing serial FEV1 monitoring may help identify children and young adults at risk for...
News
Novel device therapy shows continued benefits in pediatric peanut allergy
Viaskin Peanut now in phase III testing after positive phase IIb extension study.
Conference Coverage
Tiotropium inhalation spray effective for asthma regardless of allergic status
No need to define whether a patient has allergic or nonallergic asthma before prescribing Spiriva Respimat.